Skip to main content
ANTEOTECH LTD logo

ANTEOTECH LTD — Investor Relations & Filings

Ticker · ADO ISIN · AU000000ADO8 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,280 across all filing types
Latest filing 2015-07-27 Investor Presentation
Country AU Australia
Listing ASX ADO

About ANTEOTECH LTD

https://anteotech.com

AnteoTech Ltd is a surface chemistry company specializing in the development of proprietary nanoglue technology. The company focuses on two primary sectors: life sciences and energy. In the life sciences division, AnteoTech utilizes its AnteoBind molecular linker technology to enhance the performance of point-of-care diagnostic tests, bioprocessing, and assay development by improving the binding of biomolecules to synthetic surfaces. In the energy sector, the company develops advanced materials for lithium-ion batteries, specifically focusing on silicon anodes. Its AnteoX additive is designed to improve the electrochemical performance and structural stability of high-silicon content anodes, addressing capacity loss and cycle life challenges. The company's core value proposition lies in its ability to manipulate surface interfaces at the molecular level to optimize performance in complex chemical and biological environments.

Recent filings

Filing Released Lang Actions
AACC conference summary and CEO interview 23 pages 2.8MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation and summary related to a scientific conference (AACC) where the company's VP of Scientific Affairs presents research findings. It includes technical explanations, clinical needs, assay formats, and product descriptions related to the company's technology. There is also mention of an audio interview with the CEO providing further context. The document is lengthy (over 14,000 characters) and contains the actual presentation content, not just an announcement or a link to a report. It is not a financial report, earnings release, regulatory filing, or management discussion. The content is clearly a presentation shared during a conference, aimed at investors and stakeholders to explain the company's scientific advancements and market activities at the event. Therefore, the document fits the category of an Investor Presentation (IP).
2015-07-27 English
Anteo Entends Relationship with Sigma-Aldrich 1 pag
Regulatory Filings Classification · 95% confidence The document is a press release announcing a commercial agreement between Anteo Diagnostics and Sigma-Aldrich to incorporate Anteo's product range into Sigma-Aldrich's catalog. It contains no financial data, regulatory references, or report attachments. It is not an earnings release, annual report, or any regulatory filing. It is a corporate announcement about a business relationship and product distribution, which fits best under the category of a general regulatory announcement or miscellaneous filing that does not fit other categories.
2015-07-22 English
IMRA and Anteo move into Product Development Phase 2 pages 99.6KB
Capital/Financing Update Classification · 90% confidence The document is a corporate announcement about a product development agreement between Anteo Diagnostics Ltd and IMRA America. It discusses the completion of a feasibility study, the development of a proof of concept product, and the progression to a funded product development agreement. There is no mention of financial results, regulatory filings, management changes, or shareholder votes. The content focuses on a partnership and product development update rather than financial reporting or governance. The document length is 4667 characters, which is relatively short and typical for a corporate announcement. Therefore, this document fits best into the category of a Capital/Financing Update (CAP), as it relates to business development and partnership progress that could impact the company's capital or product pipeline.
2015-07-07 English
Boardroom Radio Interview with Dr Geoff Cumming 1 p
Regulatory Filings Classification · 95% confidence The document is a short announcement dated June 16, 2015, from Anteo Diagnostics Limited, providing information about a webcast of a radio interview with the CEO discussing recent quarterly developments. It does not contain any financial statements, detailed financial data, or comprehensive report content. The document is essentially an announcement of an event (a webcast presentation) rather than the presentation or report itself. Given the short length (767 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit other specific categories like Investor Presentation or Interim Report. It is not a full report or transcript, nor a voting or capital announcement.
2015-06-15 English
Section 708(A) Notice 1 page 322.7KB
Capital/Financing Update Classification · 100% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) from Anteo Diagnostics Ltd. It announces the issuance of 12,500,000 fully paid ordinary shares at an issue price of A$0.08 to raise $1,000,000. The notice states that the shares were issued without disclosure under Part 6D.2 of the Act and confirms compliance with relevant provisions. This is a clear update on company fundraising and capital structure changes, specifically a placement of shares. The document length is short (1235 characters) and it is not a report but a regulatory announcement about capital raising. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2015-05-31 English
Appendix 3B 13 pages 517.6KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the number and class of securities issued, issue price, purpose of the issue, shareholder approvals, and compliance with ASX rules. It includes calculations related to placement capacity under ASX rules 7.1 and 7.1A, which are specific to capital raising and share issuance. The document is a formal announcement to the ASX (Australian Securities Exchange) regarding the new issue of shares and application for quotation of additional securities. It does not contain financial statements, audit information, or management discussion, but focuses on capital structure changes and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the announcement itself, not just a brief notice or report publication announcement.
2015-05-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.